StockComparison Logo
vs

GSK vs XLV

Comparison between GSK Plc (GSK, Company) and STATE STREET(R) HEALTH CARE SELECT SECTOR SPDR(R) ETF (XLV, ETF).

Both GSK and XLV are from the Healthcare sector.

5-Year PerformanceXLV has outperformed GSK, delivering a return of +6.3% compared to +5.4%

GSK vs XLV - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap / Net Assets
Winner
GSK
$105B
XLV
$38B
Expense Ratio
GSK
N/A
XLV
0.08%
Max Drawdown
GSK
64.03%
Winner
XLV
40.58%
Sharpe Ratio
Winner
GSK
1.00
XLV
0.87
5Y Beta
Winner
GSK
0.24
XLV
0.46
Industry
GSK
Drug Manufacturers - General
XLV
N/A
P/E Ratio
Winner
GSK
12.14
XLV
28.04
Forward P/E
Winner
GSK
10.44
XLV
17.26
PEG Ratio
GSK
0.10
XLV
N/A
Dividend Yield
GSK
3.51%
XLV
N/A
5Y Dividends CAGR
GSK
1.34%
Winner
XLV
8.03%
5Y EPS CAGR
GSK
4.65%
Winner
XLV
12.40%
Debt to Equity
GSK
106.74%
Winner
XLV
53.17%
Free Cash Flow Yield
GSK
8.01%
XLV
N/A
P/S Ratio
GSK
3.16
Winner
XLV
1.45
P/B Ratio
Winner
GSK
4.30
XLV
4.53

GSK vs XLV - Historical Returns

Returns include dividend reinvestment.

1M
GSK
+3.08%
Winner
XLV
+5.31%
3M
GSK
-6.04%
Winner
XLV
-0.18%
6M
Winner
GSK
+8.15%
XLV
+0.67%
1Y
Winner
GSK
+29.75%
XLV
+17.00%
5Y(CAGR)
GSK
+5.40%
Winner
XLV
+6.31%
10Y(CAGR)
GSK
+4.36%
Winner
XLV
+9.55%
Max(CAGR)
GSK
+3.12%
Winner
XLV
+8.19%

GSK vs XLV - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearGSKXLV
2026+5.49%-1.20%
2025+50.62%+14.46%
2024-6.27%+0.70%
2023+9.25%+2.36%
2022-32.73%-1.07%
2021+23.62%+26.58%
2020-17.52%+13.04%
2019+30.36%+22.30%
2018+9.29%+5.10%
2017-3.80%+20.20%
2016+1.52%-0.98%
2015+0.48%+6.45%
2014-14.73%+25.84%
2013+26.97%+38.67%
2012-0.75%+15.87%
2011+22.51%+11.38%
2010-3.72%+1.54%
2009+20.27%+17.13%
2008-21.93%-22.50%
2007-2.77%+7.12%
2006+6.93%+5.76%
2005+9.96%+7.66%
2004+5.08%+1.05%
2003+25.04%+11.89%
2002-22.83%-1.59%
2001-9.58%+3.39%
2000+5.67%-9.87%
1999-5.78%+10.22%

GSK vs XLV Drawdown Comparison

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The maximum drawdown for XLV was -39.17%, occurring on Mar 9, 2009. Recovery took 850 trading sessions.

The current GSK drawdown is -14.42%. The current XLV drawdown is -4.10%.

RankGSKXLV
#1-50.11%
Apr 13, 2022 - Jan 6, 2026		-39.17%
Dec 10, 2007 - Apr 26, 2011
#2-49.64%
Apr 20, 2007 - Apr 18, 2012		-33.13%
Jan 10, 2000 - Jun 16, 2005
#3-45.23%
Apr 25, 2000 - Nov 11, 2005		-28.39%
Jan 22, 2020 - Jul 15, 2020
#4-32.56%
Jan 17, 2020 - Dec 10, 2021		-17.34%
May 18, 2011 - Jan 18, 2012
#5-27.97%
Mar 4, 2014 - Sep 3, 2019		-17.11%
Sep 16, 2024 - Nov 21, 2025
#6-26.98%
Nov 5, 1999 - Apr 11, 2000		-17.08%
Jul 20, 2015 - Mar 1, 2017
#7-18.61%
Feb 18, 2026 - Jun 2, 2026		-16.06%
Apr 8, 2022 - Jan 4, 2024
#8-14.45%
Jan 18, 2022 - Apr 7, 2022		-15.44%
Nov 30, 2018 - Oct 29, 2019
#9-10.52%
May 16, 2006 - Feb 13, 2007		-12.79%
Jan 26, 2018 - Aug 17, 2018
#10-10.48%
Oct 4, 2012 - Mar 22, 2013		-10.56%
Dec 30, 2021 - Apr 7, 2022
#11-8.45%
May 28, 2013 - Nov 1, 2013		-10.47%
Feb 27, 2026 - Apr 29, 2026
#12-8.43%
Apr 11, 2000 - Apr 25, 2000		-9.85%
Mar 22, 2006 - Aug 29, 2006
#13-8.16%
Nov 11, 2005 - Mar 8, 2006		-8.71%
Oct 1, 2018 - Nov 30, 2018
#14-7.54%
Feb 14, 2007 - Apr 16, 2007		-8.21%
May 7, 2007 - Nov 30, 2007
#15-7.37%
Jan 21, 2014 - Feb 13, 2014		-8.08%
Sep 3, 2021 - Dec 15, 2021

Correlation

Correlation between GSK and XLV is 0.83 which considered as a strong positive correlation - the stocks tend to move together.

0.83
-101

Dividend Comparison (1999 - 2026)

GSK vs XLV dividend yield comparison.

YearGSKXLV
20261.72%0.39%
20253.42%1.60%
20244.60%1.67%
20233.75%1.59%
20225.47%1.47%
20214.99%1.33%
20205.59%1.49%
20194.35%2.17%
20185.65%1.57%
20175.83%1.47%
20166.86%1.60%
20155.93%1.43%
20146.20%1.35%
20134.51%1.52%
20125.70%2.01%
20114.83%1.96%
20105.10%1.83%
20094.39%1.85%
20085.74%2.19%
20074.09%1.62%
20063.29%1.35%
20053.03%1.25%
20043.38%1.13%
20032.77%1.15%
20023.10%0.74%
20011.54%0.27%
20004.57%0.22%
19990.00%0.57%

Select Stocks to Compare

Popular: GSK vs SPYXLV vs SPY